Compositions and methods relating to the treatment of cancer, autoimmune disease, and neurodegenerative disease
US-2017362172-A1 · Dec 21, 2017 · US
US10508126B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10508126-B2 |
| Application number | US-201815888496-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 5, 2018 |
| Priority date | May 20, 2012 |
| Publication date | Dec 17, 2019 |
| Grant date | Dec 17, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A compound or a polymer is claimed. A first formula can be wherein X is H, CH 3 , CN, phenyl, substituted phenyl, (CH 2 ) m Z, or phenyl(CH 2 ) m Z; T is O, N, S or NH; m equals 1 to 20; n equals 1-100; and Z is CN, NH 2 , Thiol, OH, or CO 2 H. The second formula is: wherein X is H, CH 3 , CN, phenyl, substituted phenyl, (CH 2 ) m Z, or phenyl(CH 2 ) m Z; and Z is CN, NH 2 , Thiol, OH, or CO 2 H. The third formula is wherein: R 1 , R 2 , R 3 , and R 4 are independently: H, CH 3 , OH, or a halogen.
Opening claim text (preview).
What is claimed is: 1. A particle comprising a compound or a polymer comprising a formula selected from the group consisting of: wherein X is H, CH 3 , CN, phenyl, substituted phenyl, (CH 2 ) m Z, or phenyl(CH 2 ) m Z; T is O, S or NH; m equals 1 to 20; n equals 1-100; and Z is CN, NH 2 , Thiol, OH, or CO 2 H; wherein X is H, CH 3 , CN, phenyl, substituted phenyl, (CH 2 ) m Z, or phenyl(CH 2 ) m Z; and Z is CN, NH 2 , Thiol, OH, or CO 2 H; or wherein: R 1 , R 2 , R 3 , and R 4 are independently: H, CH 3 , OH, or a halogen; and wherein said particle has a particle size ranging from 40 nm to 2.2 μm. 2. The particle of claim 1 , further comprising a biologically active molecule. 3. The particle of claim 1 , wherein said compound or polymer is bound to a metallic core or a metallic oxide core via a reactive group. 4. The particle of claim 1 , wherein said polymer is water soluble. 5. An article comprising a biocompatible or a plastic core coated with the particle of any one of claims 1 and 2 - 4 . 6. A method of making the particle of claim 1 , comprising the step of free radical homopolymerization or copolymerization of monomers of the compound of (i) to (iii), in the presence of: (a) a free radical homopolymerization or copolymerization initiator; and (b) a free radical homopolymerization or copolymerization stabilizer, thereby making the particle of claim 1 . 7. The method of claim 6 , wherein said making the particle is obtained in a reaction mixture, wherein said reaction mixture comprises: 1-20% by weight of said monomers; 0.2-50% by weight of said free radical homopolymerization or copolymerization initiator; and 0.1-20% by weight of said free radical homopolymerization or copolymerization stabilizer. 8. A method of making the particle of claim 7 , comprising a Michael addition reaction including: (a) thiolating a double bond within the compound or the polymer; and (b) binding the thiolated compound or polymer to an amino group within said biologically active molecule. 9. The method of claim 8 , wherein said thiolating is obtained by 1,2-amino-thio-ethanol. 10. A method of imaging a bone in a subject, comprising the steps of: (a) administering to said subject a composition comprising an effective amount of the particle of claim 1 comprising a dye; and (b) irradiating said dye; thereby imaging a bone in a subject. 11. The method of claim 10 , wherein said dye is covalently bound to said particle. 12. The method of claim 10 , wherein said dye is physically entrapped within said particle. 13. A method of delivering a biologically active compound to a bone in a subject, comprising the step of administering to said subject a composition comprising an effective amount of the particle of claim 2 , thereby delivering a biologically active compound to a bone in a subject. 14. A method of treating a bone related disease in a subject, comprising the step of administering to said subject a composition comprising an effective amount of the particle of claim 2 , said particle of claim 2 comprises a bone related disease drug, thereby treating a bone related disease in a subject.
Drugs for skeletal disorders · CPC title
the polymer being obtained by reactions only involving carbon to carbon, e.g. poly(meth)acrylate, polystyrene, polyvinylpyrrolidone or polyvinylalcohol · CPC title
Indocyanine green, i.e. ICG, cardiogreen · CPC title
Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795 · CPC title
Macromolecular compounds, i.e. oligomers, polymers, dendrimers · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.